THE ECONOMIST: The curse of Labubu, Ozempic and ChatGPT — challenges facing Pop Mart, Novo Nordisk and OpenAI
admin 3 days agoLatest NewsComments Off on THE ECONOMIST: The curse of Labubu, Ozempic and ChatGPT — challenges facing Pop Mart, Novo Nordisk and OpenAI35 Views
THE ECONOMIST: Blockbuster products brought overnight success — and unexpected problems.